{
  "timestamp": "2026-01-08T02:26:47.666777",
  "total_queries": 86,
  "successful": 86,
  "failed": 0,
  "total_mechanisms": 850,
  "total_pathways": 25,
  "results": [
    {
      "query_id": "DG_001",
      "question": "How does capecitabine interact with DPYD c.2846A>T in cancer?",
      "elapsed_seconds": 60.471702,
      "mechanisms": [],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [],
      "overall_confidence": 0.0,
      "paper_count": 994,
      "has_sub_question_answers": true,
      "has_article_summaries": false,
      "has_moat_analysis": true,
      "run_id": "4fe774fd-5841-45d5-9148-ef452169d522"
    },
    {
      "query_id": "DG_002",
      "question": "How does capecitabine interact with DPYD c.2846A>T in cancer?",
      "elapsed_seconds": 55.170893,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "capecitabine",
          "target": "Capecitabine",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "aged",
          "target": "Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "adult",
          "target": "Adult",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "oxaliplatin",
          "target": "Oxaliplatin",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "treatment_outcome",
          "target": "Treatment Outcome",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 994,
      "has_sub_question_answers": true,
      "has_article_summaries": false,
      "has_moat_analysis": true,
      "run_id": "9000e175-0087-4749-9e66-3f029c9558b4"
    },
    {
      "query_id": "DG_003",
      "question": "How does 5-fluorouracil interact with DPYD in cancer?",
      "elapsed_seconds": 58.705518,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "ed1679e6-b3f6-49c8-9ca8-e4bae343b341"
    },
    {
      "query_id": "DG_004",
      "question": "How does 5-fluorouracil interact with DPYD in cancer?",
      "elapsed_seconds": 34.487822,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "10a78880-6e26-4a64-8d28-62e9085f2701"
    },
    {
      "query_id": "DG_005",
      "question": "How does 5-fluorouracil interact with DPYD in cancer?",
      "elapsed_seconds": 53.107638,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "d1a7fe4e-dc03-4aa8-bd46-990e6dc0fcfa"
    },
    {
      "query_id": "DG_006",
      "question": "How does 5-fluorouracil interact with DPYD in cancer?",
      "elapsed_seconds": 34.868054,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "12bc9c2d-2d13-4b4d-b5fc-cd9587be7cce"
    },
    {
      "query_id": "DG_007",
      "question": "How does 5-fluorouracil interact with DPYD in cancer?",
      "elapsed_seconds": 33.201029,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "ab0c91e6-a988-44e9-80d4-8fb8c77be622"
    },
    {
      "query_id": "DG_008",
      "question": "How does capecitabine interact with DPYD c.1903A>G in cancer?",
      "elapsed_seconds": 49.485496,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "capecitabine",
          "target": "Capecitabine",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "aged",
          "target": "Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "adult",
          "target": "Adult",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "oxaliplatin",
          "target": "Oxaliplatin",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "treatment_outcome",
          "target": "Treatment Outcome",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 994,
      "has_sub_question_answers": true,
      "has_article_summaries": false,
      "has_moat_analysis": true,
      "run_id": "d9276296-f738-4613-887f-03ce1ddb043a"
    },
    {
      "query_id": "DG_009",
      "question": "How does 5-fluorouracil interact with DPYD in cancer?",
      "elapsed_seconds": 31.300771,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "52051c6b-de78-4b05-8298-c5165d38c14b"
    },
    {
      "query_id": "DG_010",
      "question": "How does mercaptopurine interact with TPMT *3A in cancer?",
      "elapsed_seconds": 62.439296,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mercaptopurine",
          "target": "Mercaptopurine",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "precursor_cell_lymphoblastic_leukemia-lymphoma",
          "target": "Precursor Cell Lymphoblastic Leukemia-Lymphoma",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "child",
          "target": "Child",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "adolescent",
          "target": "Adolescent",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "child,_preschool",
          "target": "Child, Preschool",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "methotrexate",
          "target": "Methotrexate",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 995,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "393f7735-dd90-4d60-930a-fec52edcb42c"
    },
    {
      "query_id": "DG_011",
      "question": "How does 5-fluorouracil interact with DPYD A348T in cancer?",
      "elapsed_seconds": 47.041231,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "98b01313-333d-4056-8fc1-1e8b65b5ec44"
    },
    {
      "query_id": "DG_012",
      "question": "How does 5-fluorouracil interact with DPYD chr6:g.18139713G>T in cancer?",
      "elapsed_seconds": 44.136353,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "75ad282c-214a-4314-90df-a4fce52c9864"
    },
    {
      "query_id": "DG_013",
      "question": "How does 5-fluorouracil interact with DPYD chr6:g.18130698delA in cancer?",
      "elapsed_seconds": 43.338893,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "57a10c38-9245-40db-b733-da11f194d9e0"
    },
    {
      "query_id": "DG_014",
      "question": "How does 5-fluorouracil interact with DPYD chr6:g.18149023G>A in cancer?",
      "elapsed_seconds": 45.352068,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "69eeaef1-8f90-4b20-858a-fc5b11c439be"
    },
    {
      "query_id": "DG_015",
      "question": "How does 5-fluorouracil interact with DPYD chr6:g.18130729C>T in cancer?",
      "elapsed_seconds": 45.742351,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "a1ded54f-c9b1-499f-9020-8a093c2cb4bd"
    },
    {
      "query_id": "DG_016",
      "question": "How does 5-fluorouracil interact with DPYD chr6:g.18133864G>A in cancer?",
      "elapsed_seconds": 41.738584,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "30cb79a2-1d3f-40ae-8e1a-a7188e037d26"
    },
    {
      "query_id": "DG_017",
      "question": "How does 5-fluorouracil interact with DPYD chr6:g.18143662delA in cancer?",
      "elapsed_seconds": 46.904043,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "19f454b8-2210-457a-ae47-544734547c89"
    },
    {
      "query_id": "DG_018",
      "question": "How does 5-fluorouracil interact with DPYD chr6:g.18143717C>A in cancer?",
      "elapsed_seconds": 73.095456,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 897,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "48fdd58f-9298-4868-92dc-b118bf777dc2"
    },
    {
      "query_id": "DG_019",
      "question": "How does 5-fluorouracil interact with DPYD chr6:g.18130763G>A in cancer?",
      "elapsed_seconds": 44.402992,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "6ff829df-ef05-4813-b10a-ff07c77d4aca"
    },
    {
      "query_id": "DG_020",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97679174G>A in cancer?",
      "elapsed_seconds": 42.721082,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "fcf8d170-f38a-490a-a90d-2566511ea5be"
    },
    {
      "query_id": "DG_021",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97828158C>A in cancer?",
      "elapsed_seconds": 47.131858,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "f7e0477a-61e0-440b-b7f6-0d520fa09af7"
    },
    {
      "query_id": "DG_022",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97573967C>A in cancer?",
      "elapsed_seconds": 47.420171,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "9a2a90f1-e66f-46f9-bfde-16b97911024e"
    },
    {
      "query_id": "DG_023",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97721603A>G in cancer?",
      "elapsed_seconds": 48.414463,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "f00443e7-580a-4328-b7e5-64e5fe7d6634"
    },
    {
      "query_id": "DG_024",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97079145G>T in cancer?",
      "elapsed_seconds": 42.269637,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "1f902f09-c74b-4aa1-9673-2e754a132890"
    },
    {
      "query_id": "DG_025",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97306282G>A in cancer?",
      "elapsed_seconds": 42.535066,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "27812c48-4f65-49c8-908f-6773739abe0b"
    },
    {
      "query_id": "DG_026",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97593336A>G in cancer?",
      "elapsed_seconds": 45.705436,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "ff8184f6-b02b-44ab-895c-aad86f33bae7"
    },
    {
      "query_id": "DG_027",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97306235delA in cancer?",
      "elapsed_seconds": 43.265679,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "f216f08a-f31c-4e38-b3bd-9397031650fe"
    },
    {
      "query_id": "DG_028",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97573918C>T in cancer?",
      "elapsed_seconds": 45.854462,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "8a152f4e-5a0a-41ed-bda4-f3842f438269"
    },
    {
      "query_id": "DG_029",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97079073C>T in cancer?",
      "elapsed_seconds": 47.815149,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "aa9babe5-671f-41f0-a04d-f4d7074103b4"
    },
    {
      "query_id": "DG_030",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97883365C>T in cancer?",
      "elapsed_seconds": 45.291761,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "64134dcd-2995-457e-b74f-bc2ff0b849c7"
    },
    {
      "query_id": "DG_031",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97679126T>G in cancer?",
      "elapsed_seconds": 44.373956,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "b6846855-f0d7-4d2f-8db2-5b33f06f348e"
    },
    {
      "query_id": "DG_032",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97082458T>C in cancer?",
      "elapsed_seconds": 46.48082,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "6766ad62-1783-48a0-abfb-d0092ed61cdd"
    },
    {
      "query_id": "DG_033",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97721543A>G in cancer?",
      "elapsed_seconds": 48.500342,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "e62068eb-012e-4191-a80d-58fe67a31ffc"
    },
    {
      "query_id": "DG_034",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97699457G>A in cancer?",
      "elapsed_seconds": 45.552366,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "c19f9897-2a4c-4390-9f7e-f667d1d66576"
    },
    {
      "query_id": "DG_035",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97515906T>G in cancer?",
      "elapsed_seconds": 45.921878,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "d1ccb0ea-a188-4123-87a6-c7f5d3ac05ed"
    },
    {
      "query_id": "DG_036",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97234900A>G in cancer?",
      "elapsed_seconds": 49.509043,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "7de98446-0f2d-43bd-82e4-8c5f314f619d"
    },
    {
      "query_id": "DG_037",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97721569A>C in cancer?",
      "elapsed_seconds": 43.652674,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "17e3b9e4-3eab-4a75-aa4a-d206762bedb5"
    },
    {
      "query_id": "DG_038",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97549703G>T in cancer?",
      "elapsed_seconds": 45.376019,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "8235d234-78e1-4505-a2e4-b182f1debad4"
    },
    {
      "query_id": "DG_039",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97595138G>T in cancer?",
      "elapsed_seconds": 45.4794,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "de73b281-83c3-40d3-95ac-8a3102236e83"
    },
    {
      "query_id": "DG_040",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97306195C>T in cancer?",
      "elapsed_seconds": 43.473052,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fluorouracil",
          "target": "Fluorouracil",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_combined_chemotherapy_protocols",
          "target": "Antineoplastic Combined Chemotherapy Protocols",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "eaf8c7a0-dbca-4215-a182-19eea2ed9a9f"
    },
    {
      "query_id": "SL_001",
      "question": "What mechanisms does Olaparib target in ovarian cancer with p.C61G?",
      "elapsed_seconds": 64.395796,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_neoplasms",
          "target": "Ovarian Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_cancer",
          "target": "ovarian cancer",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "carcinoma,_ovarian_epithelial",
          "target": "Carcinoma, Ovarian Epithelial",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "4663ee49-2f41-4782-a6af-7d76a1250669"
    },
    {
      "query_id": "SL_002",
      "question": "What mechanisms does Olaparib target in breast cancer with p.C61G?",
      "elapsed_seconds": 60.444454,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "breast_neoplasms",
          "target": "Breast Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "brca1_protein",
          "target": "BRCA1 Protein",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "triple_negative_breast_neoplasms",
          "target": "Triple Negative Breast Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [
        "dna_repair"
      ],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 996,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "55bbf080-c55f-46c8-afa3-c2a24df25d15"
    },
    {
      "query_id": "SL_003",
      "question": "What mechanisms does Olaparib target in prostate cancer with p.K3326*?",
      "elapsed_seconds": 54.426247,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostatic_neoplasms,_castration-resistant",
          "target": "Prostatic Neoplasms, Castration-Resistant",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostatic_neoplasms",
          "target": "Prostatic Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostate_cancer",
          "target": "prostate cancer",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mutation",
          "target": "Mutation",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [
        "oxidative_stress"
      ],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 524,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "b510b360-e329-4d37-80c5-08341e22d02d"
    },
    {
      "query_id": "SL_004",
      "question": "What mechanisms does Olaparib target in ovarian cancer with p.K3326*?",
      "elapsed_seconds": 60.020236,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_neoplasms",
          "target": "Ovarian Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_cancer",
          "target": "ovarian cancer",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "carcinoma,_ovarian_epithelial",
          "target": "Carcinoma, Ovarian Epithelial",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "efea7c2d-6f0d-4e24-a7fb-9346cfb5c7c4"
    },
    {
      "query_id": "SL_005",
      "question": "What mechanisms does Olaparib target in breast cancer with p.R346fs?",
      "elapsed_seconds": 57.66298,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "breast_neoplasms",
          "target": "Breast Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "brca1_protein",
          "target": "BRCA1 Protein",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "triple_negative_breast_neoplasms",
          "target": "Triple Negative Breast Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [
        "dna_repair"
      ],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 996,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "bd64110e-646c-4c0e-86c2-ef652b2739f3"
    },
    {
      "query_id": "SL_006",
      "question": "What mechanisms does Ceralasertib target in prostate cancer with p.R175H?",
      "elapsed_seconds": 42.023861,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "indoles",
          "target": "Indoles",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "pyrimidines",
          "target": "Pyrimidines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ataxia_telangiectasia_mutated_proteins",
          "target": "Ataxia Telangiectasia Mutated Proteins",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "morpholines",
          "target": "Morpholines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "sulfonamides",
          "target": "Sulfonamides",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 4,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "ebd6c741-dc22-4293-8c83-b9a007098d61"
    },
    {
      "query_id": "SL_007",
      "question": "What mechanisms does Adavosertib target in ovarian cancer with p.R175H?",
      "elapsed_seconds": 39.254801,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "pyrazoles",
          "target": "Pyrazoles",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "pyrimidinones",
          "target": "Pyrimidinones",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_neoplasms",
          "target": "Ovarian Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_cycle_proteins",
          "target": "Cell Cycle Proteins",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "protein-tyrosine_kinases",
          "target": "Protein-Tyrosine Kinases",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [
        "oxidative_stress"
      ],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 36,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "4fb4d0ca-6833-4b04-8f08-9e8c83471a82"
    },
    {
      "query_id": "SL_008",
      "question": "What mechanisms does Olaparib target in breast cancer with p.??",
      "elapsed_seconds": 58.469877,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "breast_neoplasms",
          "target": "Breast Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "brca1_protein",
          "target": "BRCA1 Protein",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "triple_negative_breast_neoplasms",
          "target": "Triple Negative Breast Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [
        "dna_repair"
      ],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 996,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "e9e15055-805d-4e78-9678-a89f6915ae44"
    },
    {
      "query_id": "SL_009",
      "question": "What mechanisms does Olaparib target in prostate cancer with p.??",
      "elapsed_seconds": 46.60729,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostatic_neoplasms,_castration-resistant",
          "target": "Prostatic Neoplasms, Castration-Resistant",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostatic_neoplasms",
          "target": "Prostatic Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostate_cancer",
          "target": "prostate cancer",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mutation",
          "target": "Mutation",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [
        "oxidative_stress"
      ],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 524,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "71f6e3dd-c619-4593-8228-ebb051674696"
    },
    {
      "query_id": "SL_010",
      "question": "What mechanisms does Olaparib target in ovarian cancer with p.??",
      "elapsed_seconds": 58.510126,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_neoplasms",
          "target": "Ovarian Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_cancer",
          "target": "ovarian cancer",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "carcinoma,_ovarian_epithelial",
          "target": "Carcinoma, Ovarian Epithelial",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "241a4583-40e5-4c31-8b63-885e40447530"
    },
    {
      "query_id": "SL_011",
      "question": "What mechanisms does Olaparib target in breast cancer with p.??",
      "elapsed_seconds": 59.027615,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "breast_neoplasms",
          "target": "Breast Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "brca1_protein",
          "target": "BRCA1 Protein",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "triple_negative_breast_neoplasms",
          "target": "Triple Negative Breast Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [
        "dna_repair"
      ],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 996,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "0c445135-7859-41c1-8221-62288c740e4b"
    },
    {
      "query_id": "SL_012",
      "question": "What mechanisms does Ceralasertib target in prostate cancer with p.??",
      "elapsed_seconds": 36.304083,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "indoles",
          "target": "Indoles",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "pyrimidines",
          "target": "Pyrimidines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ataxia_telangiectasia_mutated_proteins",
          "target": "Ataxia Telangiectasia Mutated Proteins",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "morpholines",
          "target": "Morpholines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "sulfonamides",
          "target": "Sulfonamides",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 4,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "a50b8c2e-f48e-4e77-8219-f2a9564e4e4f"
    },
    {
      "query_id": "SL_013",
      "question": "What mechanisms does Olaparib target in ovarian cancer with p.??",
      "elapsed_seconds": 55.670386,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_neoplasms",
          "target": "Ovarian Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_cancer",
          "target": "ovarian cancer",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "carcinoma,_ovarian_epithelial",
          "target": "Carcinoma, Ovarian Epithelial",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "4a64385f-7fc5-4bf5-8d17-523faf4eae19"
    },
    {
      "query_id": "SL_014",
      "question": "What mechanisms does Olaparib target in breast cancer with p.C61G?",
      "elapsed_seconds": 59.221074,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "breast_neoplasms",
          "target": "Breast Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "brca1_protein",
          "target": "BRCA1 Protein",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "triple_negative_breast_neoplasms",
          "target": "Triple Negative Breast Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [
        "dna_repair"
      ],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 996,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "1615679c-d834-450a-acc3-ac3b759a508e"
    },
    {
      "query_id": "SL_015",
      "question": "What mechanisms does Olaparib target in prostate cancer with p.C61G?",
      "elapsed_seconds": 48.752177,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostatic_neoplasms,_castration-resistant",
          "target": "Prostatic Neoplasms, Castration-Resistant",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostatic_neoplasms",
          "target": "Prostatic Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostate_cancer",
          "target": "prostate cancer",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mutation",
          "target": "Mutation",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [
        "oxidative_stress"
      ],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 524,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "1dbbb678-c768-42a6-aa38-6d1e60c06fd5"
    },
    {
      "query_id": "SL_016",
      "question": "What mechanisms does Olaparib target in ovarian cancer with p.K3326*?",
      "elapsed_seconds": 56.388526,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_neoplasms",
          "target": "Ovarian Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_cancer",
          "target": "ovarian cancer",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "carcinoma,_ovarian_epithelial",
          "target": "Carcinoma, Ovarian Epithelial",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "87f3f9c7-f8e7-41ad-9d74-56aee91ccc1d"
    },
    {
      "query_id": "SL_017",
      "question": "What mechanisms does Olaparib target in breast cancer with p.K3326*?",
      "elapsed_seconds": 93.574745,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "breast_neoplasms",
          "target": "Breast Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "brca1_protein",
          "target": "BRCA1 Protein",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "triple_negative_breast_neoplasms",
          "target": "Triple Negative Breast Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [
        "dna_repair"
      ],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 996,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "2b468b57-380d-4cef-98aa-9da1ba5c09ef"
    },
    {
      "query_id": "SL_018",
      "question": "What mechanisms does Olaparib target in prostate cancer with p.R346fs?",
      "elapsed_seconds": 49.508414,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostatic_neoplasms,_castration-resistant",
          "target": "Prostatic Neoplasms, Castration-Resistant",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostatic_neoplasms",
          "target": "Prostatic Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostate_cancer",
          "target": "prostate cancer",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mutation",
          "target": "Mutation",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [
        "oxidative_stress"
      ],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 524,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "3613c545-d643-4041-ad9d-a6f9723dfb02"
    },
    {
      "query_id": "SL_019",
      "question": "What mechanisms does Ceralasertib target in ovarian cancer with p.R175H?",
      "elapsed_seconds": 40.445136,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_neoplasms",
          "target": "Ovarian Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "indoles",
          "target": "Indoles",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ataxia_telangiectasia_mutated_proteins",
          "target": "Ataxia Telangiectasia Mutated Proteins",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "morpholines",
          "target": "Morpholines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "pyrimidines",
          "target": "Pyrimidines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "sulfonamides",
          "target": "Sulfonamides",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 17,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "7fbe08cb-0f45-471d-a039-98c79d661c0a"
    },
    {
      "query_id": "SL_020",
      "question": "What mechanisms does Adavosertib target in breast cancer with p.R175H?",
      "elapsed_seconds": 43.155837,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_cycle_proteins",
          "target": "Cell Cycle Proteins",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "protein-tyrosine_kinases",
          "target": "Protein-Tyrosine Kinases",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "pyrazoles",
          "target": "Pyrazoles",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "pyrimidinones",
          "target": "Pyrimidinones",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "protein_kinase_inhibitors",
          "target": "Protein Kinase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [
        "oxidative_stress"
      ],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 30,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "de577ff0-abfa-4b44-97fb-fea2b8c9bb99"
    },
    {
      "query_id": "SL_021",
      "question": "What mechanisms does Olaparib target in prostate cancer with p.??",
      "elapsed_seconds": 51.55046,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostatic_neoplasms,_castration-resistant",
          "target": "Prostatic Neoplasms, Castration-Resistant",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostatic_neoplasms",
          "target": "Prostatic Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostate_cancer",
          "target": "prostate cancer",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mutation",
          "target": "Mutation",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [
        "oxidative_stress"
      ],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 524,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "4db2c28a-1431-40f4-940f-d15d4b3e6369"
    },
    {
      "query_id": "SL_022",
      "question": "What mechanisms does Olaparib target in ovarian cancer with p.??",
      "elapsed_seconds": 58.233373,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_neoplasms",
          "target": "Ovarian Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_cancer",
          "target": "ovarian cancer",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "carcinoma,_ovarian_epithelial",
          "target": "Carcinoma, Ovarian Epithelial",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "8d28efe8-d8f9-41cf-8773-5955a7782433"
    },
    {
      "query_id": "SL_023",
      "question": "What mechanisms does Olaparib target in breast cancer with p.??",
      "elapsed_seconds": 62.345246,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "breast_neoplasms",
          "target": "Breast Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "brca1_protein",
          "target": "BRCA1 Protein",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "triple_negative_breast_neoplasms",
          "target": "Triple Negative Breast Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [
        "dna_repair"
      ],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 996,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "775a8204-dcb3-4665-87b9-97ec10402ceb"
    },
    {
      "query_id": "SL_024",
      "question": "What mechanisms does Olaparib target in prostate cancer with p.??",
      "elapsed_seconds": 47.069008,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostatic_neoplasms,_castration-resistant",
          "target": "Prostatic Neoplasms, Castration-Resistant",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostatic_neoplasms",
          "target": "Prostatic Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostate_cancer",
          "target": "prostate cancer",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mutation",
          "target": "Mutation",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [
        "oxidative_stress"
      ],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 524,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "ee5ebff6-6ee8-4230-b397-6fb24be30f2f"
    },
    {
      "query_id": "SL_025",
      "question": "What mechanisms does Ceralasertib target in ovarian cancer with p.??",
      "elapsed_seconds": 36.823619,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_neoplasms",
          "target": "Ovarian Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "indoles",
          "target": "Indoles",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ataxia_telangiectasia_mutated_proteins",
          "target": "Ataxia Telangiectasia Mutated Proteins",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "morpholines",
          "target": "Morpholines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "pyrimidines",
          "target": "Pyrimidines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "sulfonamides",
          "target": "Sulfonamides",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 17,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "0908b07c-9ae3-4f9d-90b2-c927b80325b3"
    },
    {
      "query_id": "SL_026",
      "question": "What mechanisms does Olaparib target in breast cancer with p.??",
      "elapsed_seconds": 59.037334,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "breast_neoplasms",
          "target": "Breast Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "brca1_protein",
          "target": "BRCA1 Protein",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "triple_negative_breast_neoplasms",
          "target": "Triple Negative Breast Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [
        "dna_repair"
      ],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 996,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "ca17fb65-2d5e-4fcc-9805-a1b205b90674"
    },
    {
      "query_id": "SL_027",
      "question": "What mechanisms does Olaparib target in prostate cancer with p.C61G?",
      "elapsed_seconds": 49.62598,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostatic_neoplasms,_castration-resistant",
          "target": "Prostatic Neoplasms, Castration-Resistant",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostatic_neoplasms",
          "target": "Prostatic Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostate_cancer",
          "target": "prostate cancer",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mutation",
          "target": "Mutation",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [
        "oxidative_stress"
      ],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 524,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "ecd482c8-30b3-40d1-8747-048f3dce05a6"
    },
    {
      "query_id": "SL_028",
      "question": "What mechanisms does Olaparib target in ovarian cancer with p.C61G?",
      "elapsed_seconds": 67.286407,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_neoplasms",
          "target": "Ovarian Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_cancer",
          "target": "ovarian cancer",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "carcinoma,_ovarian_epithelial",
          "target": "Carcinoma, Ovarian Epithelial",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "8c7a42ca-fecb-4941-9f1f-839257249daa"
    },
    {
      "query_id": "SL_029",
      "question": "What mechanisms does Olaparib target in breast cancer with p.K3326*?",
      "elapsed_seconds": 61.109086,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "breast_neoplasms",
          "target": "Breast Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "brca1_protein",
          "target": "BRCA1 Protein",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "triple_negative_breast_neoplasms",
          "target": "Triple Negative Breast Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [
        "dna_repair"
      ],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 996,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "71db2364-2b7f-49c0-b5e7-eb13636ae6b7"
    },
    {
      "query_id": "SL_030",
      "question": "What mechanisms does Olaparib target in prostate cancer with p.K3326*?",
      "elapsed_seconds": 54.652469,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostatic_neoplasms,_castration-resistant",
          "target": "Prostatic Neoplasms, Castration-Resistant",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostatic_neoplasms",
          "target": "Prostatic Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostate_cancer",
          "target": "prostate cancer",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mutation",
          "target": "Mutation",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [
        "oxidative_stress"
      ],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 524,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "b9efd8fe-9a29-43a3-ab3f-75a5cead1622"
    },
    {
      "query_id": "SL_031",
      "question": "What mechanisms does Olaparib target in ovarian cancer with p.R346fs?",
      "elapsed_seconds": 58.990203,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_neoplasms",
          "target": "Ovarian Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_cancer",
          "target": "ovarian cancer",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "carcinoma,_ovarian_epithelial",
          "target": "Carcinoma, Ovarian Epithelial",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "a4c9cfe1-8ed5-4d51-84c0-efaca921b78a"
    },
    {
      "query_id": "SL_032",
      "question": "What mechanisms does Ceralasertib target in breast cancer with p.R175H?",
      "elapsed_seconds": 42.999745,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "pyrimidines",
          "target": "Pyrimidines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "indoles",
          "target": "Indoles",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "morpholines",
          "target": "Morpholines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "sulfonamides",
          "target": "Sulfonamides",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ataxia_telangiectasia_mutated_proteins",
          "target": "Ataxia Telangiectasia Mutated Proteins",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 14,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "054d6f0d-a93d-4a96-bc16-da87017c55f4"
    },
    {
      "query_id": "SL_033",
      "question": "What mechanisms does Adavosertib target in prostate cancer with p.R175H?",
      "elapsed_seconds": 43.368664,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "pyrazoles",
          "target": "Pyrazoles",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_cycle_proteins",
          "target": "Cell Cycle Proteins",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "protein-tyrosine_kinases",
          "target": "Protein-Tyrosine Kinases",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "pyrimidinones",
          "target": "Pyrimidinones",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [
        "oxidative_stress"
      ],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 6,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "36ca9df1-cb56-4729-81ab-3b3733562f43"
    },
    {
      "query_id": "SL_034",
      "question": "What mechanisms does Olaparib target in ovarian cancer with p.??",
      "elapsed_seconds": 58.204088,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_neoplasms",
          "target": "Ovarian Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_cancer",
          "target": "ovarian cancer",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "carcinoma,_ovarian_epithelial",
          "target": "Carcinoma, Ovarian Epithelial",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "ae3e55ba-84b3-40d4-ae3c-347ef49f1ad6"
    },
    {
      "query_id": "SL_035",
      "question": "What mechanisms does Olaparib target in breast cancer with p.??",
      "elapsed_seconds": 63.650274,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "breast_neoplasms",
          "target": "Breast Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "brca1_protein",
          "target": "BRCA1 Protein",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "triple_negative_breast_neoplasms",
          "target": "Triple Negative Breast Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [
        "dna_repair"
      ],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 996,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "82dbae6e-3220-4f32-86b3-928f7dee249e"
    },
    {
      "query_id": "SL_036",
      "question": "What mechanisms does Olaparib target in prostate cancer with p.??",
      "elapsed_seconds": 42.89993,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostatic_neoplasms,_castration-resistant",
          "target": "Prostatic Neoplasms, Castration-Resistant",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostatic_neoplasms",
          "target": "Prostatic Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostate_cancer",
          "target": "prostate cancer",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mutation",
          "target": "Mutation",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [
        "oxidative_stress"
      ],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 524,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "c5374fe2-d305-4d01-b090-55fe4cd5bae0"
    },
    {
      "query_id": "SL_037",
      "question": "What mechanisms does Olaparib target in ovarian cancer with p.??",
      "elapsed_seconds": 59.240622,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_neoplasms",
          "target": "Ovarian Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_cancer",
          "target": "ovarian cancer",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "carcinoma,_ovarian_epithelial",
          "target": "Carcinoma, Ovarian Epithelial",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "37b4ac3b-94ab-41d3-88f5-2e147b5bc6eb"
    },
    {
      "query_id": "SL_038",
      "question": "What mechanisms does Ceralasertib target in breast cancer with p.??",
      "elapsed_seconds": 47.762835,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "pyrimidines",
          "target": "Pyrimidines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "indoles",
          "target": "Indoles",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "morpholines",
          "target": "Morpholines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "sulfonamides",
          "target": "Sulfonamides",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ataxia_telangiectasia_mutated_proteins",
          "target": "Ataxia Telangiectasia Mutated Proteins",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 14,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "f98a4b7f-8369-4cac-9aaa-dc6ea659daa1"
    },
    {
      "query_id": "SL_039",
      "question": "What mechanisms does Olaparib target in prostate cancer with p.??",
      "elapsed_seconds": 41.177888,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostatic_neoplasms,_castration-resistant",
          "target": "Prostatic Neoplasms, Castration-Resistant",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostatic_neoplasms",
          "target": "Prostatic Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "prostate_cancer",
          "target": "prostate cancer",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mutation",
          "target": "Mutation",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [
        "oxidative_stress"
      ],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 524,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "7f2b6b4d-9e76-422e-ace1-e9d2af44b141"
    },
    {
      "query_id": "SL_040",
      "question": "What mechanisms does Olaparib target in ovarian cancer with p.C61G?",
      "elapsed_seconds": 57.574048,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_neoplasms",
          "target": "Ovarian Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "poly(adp-ribose)_polymerase_inhibitors",
          "target": "Poly(ADP-ribose) Polymerase Inhibitors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "phthalazines",
          "target": "Phthalazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "piperazines",
          "target": "Piperazines",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_cancer",
          "target": "ovarian cancer",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "carcinoma,_ovarian_epithelial",
          "target": "Carcinoma, Ovarian Epithelial",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 997,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "7bf6d83f-9de3-47d5-b57f-6b7610073615"
    },
    {
      "query_id": "HV_001",
      "question": "How does Vitamin D help with ovarian cancer?",
      "elapsed_seconds": 43.186863,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "vitamin_d",
          "target": "Vitamin D",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_neoplasms",
          "target": "Ovarian Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "risk_factors",
          "target": "Risk Factors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "receptors,_calcitriol",
          "target": "Receptors, Calcitriol",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "aged",
          "target": "Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "adult",
          "target": "Adult",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "male",
          "target": "Male",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 341,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "3aa2b188-4a14-4389-9963-f6f83a042811"
    },
    {
      "query_id": "HV_002",
      "question": "How does Omega-3 Fatty Acids (EPA/DHA) help with ovarian cancer?",
      "elapsed_seconds": 39.621902,
      "mechanisms": [
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_neoplasms",
          "target": "Ovarian Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "fatty_acids,_omega-3",
          "target": "Fatty Acids, Omega-3",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "apoptosis",
          "target": "Apoptosis",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_cancer",
          "target": "Ovarian cancer",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "diet",
          "target": "Diet",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "chickens",
          "target": "Chickens",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [
        "apoptosis"
      ],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 31,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "16e05815-ddee-43d7-be01-ea745806ea8f"
    },
    {
      "query_id": "HV_003",
      "question": "How does Folate + Vitamin B12 help with ovarian cancer?",
      "elapsed_seconds": 39.68574,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_neoplasms",
          "target": "Ovarian Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "middle_aged",
          "target": "Middle Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "vitamin_b_12",
          "target": "Vitamin B 12",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "vitamin_b_complex",
          "target": "Vitamin B Complex",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "adult",
          "target": "Adult",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "folic_acid",
          "target": "Folic Acid",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "aged",
          "target": "Aged",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 40,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "ef6d1fdf-e6df-4ebb-ba79-d33d500c6aa7"
    },
    {
      "query_id": "HV_004",
      "question": "How does Curcumin (Turmeric) help with ovarian cancer?",
      "elapsed_seconds": 45.437375,
      "mechanisms": [
        {
          "mechanism": "curcumin",
          "target": "Curcumin",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_neoplasms",
          "target": "Ovarian Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "antineoplastic_agents",
          "target": "Antineoplastic Agents",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "apoptosis",
          "target": "Apoptosis",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_proliferation",
          "target": "Cell Proliferation",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "drug_resistance,_neoplasm",
          "target": "Drug Resistance, Neoplasm",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [
        "apoptosis"
      ],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 258,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "d845c576-09a3-4d27-af67-f127ab011f20"
    },
    {
      "query_id": "HV_005",
      "question": "How does Green Tea (EGCG) help with ovarian cancer?",
      "elapsed_seconds": 38.245099,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "tea",
          "target": "Tea",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_neoplasms",
          "target": "Ovarian Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "catechin",
          "target": "Catechin",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "animals",
          "target": "Animals",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "risk_factors",
          "target": "Risk Factors",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "mice",
          "target": "Mice",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_cancer",
          "target": "ovarian cancer",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 78,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "7c503fd5-f072-4f58-8834-ef8cc4ba6410"
    },
    {
      "query_id": "HV_006",
      "question": "How does NAC (N-Acetylcysteine) help with ovarian cancer?",
      "elapsed_seconds": 41.122466,
      "mechanisms": [
        {
          "mechanism": "humans",
          "target": "Humans",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "autophagy",
          "target": "Autophagy",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "female",
          "target": "Female",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "proto-oncogene_proteins_p21(ras)",
          "target": "Proto-Oncogene Proteins p21(ras)",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "reactive_oxygen_species",
          "target": "Reactive Oxygen Species",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "cell_line,_tumor",
          "target": "Cell Line, Tumor",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "ovarian_neoplasms",
          "target": "Ovarian Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "pancreatic_neoplasms",
          "target": "Pancreatic Neoplasms",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "carcinoma,_pancreatic_ductal",
          "target": "Carcinoma, Pancreatic Ductal",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        },
        {
          "mechanism": "chloroquine",
          "target": "Chloroquine",
          "evidence": "Keyword frequency analysis",
          "confidence": 0.5,
          "sources": []
        }
      ],
      "pathways": [],
      "evidence_tier": "Insufficient",
      "badges": [
        "RCT"
      ],
      "overall_confidence": 0.5,
      "paper_count": 2,
      "has_sub_question_answers": true,
      "has_article_summaries": true,
      "has_moat_analysis": true,
      "run_id": "30cfd5db-711e-450b-a089-776afa46f2e0"
    }
  ]
}